Cargando…
1688P Outcome of older cancer patients infected with COVID-19 at Gustave Roussy Cancer Center
Autores principales: | Hauchecorne, M., Baldini, C., Foulon, S., Bayle, A., Gachot, B., Pommeret, F., Willekens, C., Griscelli, F., Netzer, F., Balleyguier, C., Ammari, S., André, F., Scotté, F., Besse, B., Soria, J-C., Barlesi, F., Albiges, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506356/ http://dx.doi.org/10.1016/j.annonc.2020.08.1752 |
Ejemplares similares
-
1639P Impact of COVID-19 on ongoing oncological and hematological treatment strategy
por: Bayle, A., et al.
Publicado: (2021) -
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
por: Michot, J.-M., et al.
Publicado: (2020) -
Severe COVID-19 in patients with hematological cancers presenting with viremia
por: Michot, J.M., et al.
Publicado: (2021) -
Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy
por: Recondo, Gonzalo, et al.
Publicado: (2020) -
Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy
por: Theodore, Ch, et al.
Publicado: (2004)